News tagged with ribavirin
Related topics: hepatitis c
US panel gives nod to Merck hepatitis C drug
A US government advisory committee on Wednesday unanimously voted to urge the Food and Drug Administration to approve a new drug made by Merck to fight hepatitis C, a disease which attacks the liver.
Medicine & Health / Medications
Apr 27, 2011 |
5 / 5 (1) |
0
Initial Hepatitis C drug trial complete
The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed.
Medicine & Health / Medications
Sep 02, 2010 |
not rated yet |
0
New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment
Adding a direct acting anti-viral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult to treat patients, according to a research report published Monday in the ...
Medicine & Health / Diseases, Conditions, Syndromes
Aug 08, 2010 |
5 / 5 (3) |
0
Trials begin on potent new hepatitis C drug
The first clinical trials have started on a new investigational drug, discovered by researchers at Cardiff University, which is being developed to treat infections caused by Hepatitis C virus.
Medicine & Health / Medications
May 14, 2010 |
not rated yet |
0
Hepatitis C treatment less effective in urban minority patients
A recent study confirms that the standard hepatitis C (HCV) therapy, pegylated interferon and ribavirin, is significantly less effective in urban minority patients treated in an ordinary clinical practice setting compared ...
Medicine & Health / Diseases, Conditions, Syndromes
Mar 25, 2010 |
not rated yet |
0
Added anti-viral improves response, halves duration of hepatitis C treatment
The addition of the anti-viral drug telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and increase the number of patients who can be cured of their disease, according to the results of ...
Medicine & Health / Diseases, Conditions, Syndromes
Apr 30, 2009 |
1 / 5 (1) |
0
Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment
Berlin, Germany, Saturday 02 April 2011: Exciting new data presented today at the International Liver CongressTM 2011 show that quadruple therapy in chronic hepatitis C (HCV) patients suppressed the emergence of resistant ...
Medicine & Health / Diseases, Conditions, Syndromes
Apr 02, 2011 |
not rated yet |
0
Data suggest liver experts should take care when prescribing novel antiviral HCV drugs
Data presented at the International Liver Congress highlight the fact that new novel antiviral compounds for the treatment of hepatitis C virus (HCV) must be prescribed and monitored by experts and specialists to ensure resistance ...
Medicine & Health / Diseases, Conditions, Syndromes
Apr 02, 2011 |
not rated yet |
0
The future looks bright for HCV patients who have failed to respond to current treatments
Berlin, Germany, Friday 1st April 2011: Highly anticipated data from a number of clinical trials presented for the first time at the International Liver CongressTM confirmed that a range of new proteases inhibitors will help ...
Medicine & Health / Diseases, Conditions, Syndromes
Apr 01, 2011 |
5 / 5 (1) |
0
Depression overlooked in patients with hepatitis C; compromising HCV therapy
Researchers from Denmark, Sweden, Norway and Finland (the NORDynamIC project group) have observed that depressive symptoms in patients with hepatitis C virus (HCV) infection are commonly overlooked in routine clinical interviews, ...
Medicine & Health / Diseases, Conditions, Syndromes
Jul 20, 2010 |
not rated yet |
0
